Myocardial infarction should, as we know, be treated by immediate percutaneous coronary intervention, but even this doesn’t always restore an adequate circulation to the ischaemic area, so we can expect new trials of MI interventions for the foreseeable future. We can also expect that many of the drugs in future trials will end with the suffix “mab
JAMA 3 Jan 2007
